Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase 1 4Phase 3 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 71INDUSTRY 38NIH 19NETWORK 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 84Gemcitabine 74Carboplatin 67Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × Lapatinib × Clear all
NCT01711658 2023-10-17

TRYHARD

Radiation Therapy Oncology Group

Phase 2 Completed
142 enrolled 22 charts
Head & Neck

Head and Neck Neoplasms

NCT01485926 2018-08-06

TCHL Phase II

Cancer Trials Ireland

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms

NCT01123473 2016-10-12

Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
29 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00962312 2014-12-31

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Cancer Trials Ireland

Phase 2 Completed
9 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡